PROGNOSTIC FACTORS IN HUMAN PANCREATIC-CANCER, WITH SPECIAL REFERENCE TO QUANTITATIVE HISTOLOGY

被引:38
作者
ESKELINEN, M
LIPPONEN, P
MARIN, S
HAAPASALO, H
MAKINEN, K
AHTOLA, H
PUITTINEN, J
NUUTINEN, P
ALHAVA, E
机构
[1] UNIV KUOPIO,CENT HOSP,DEPT PATHOL,SF-70210 KUOPIO,FINLAND
[2] MIKKELI CENT HOSP,MIKKELI,FINLAND
[3] SAVONLINNA CENT HOSP,SAVONLINNA,FINLAND
[4] CENT HOSP P KARJALA,JOENSUU,FINLAND
关键词
HISTOLOGIC GRADE; NUCLEAR MORPHOMETRY; PANCREATIC CANCER; SURVIVAL; VOLUME-CORRECTED MITOTIC INDEX;
D O I
10.3109/00365529108998570
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A retrospective clinicopathologic study was done on 111 patients with a pancreatic ductal adenocarcinoma. The mean follow-up period was 6 years. By means of interactive morphometry six nuclear morphometric features were measured in biopsy specimens from the primary tumours. Volume-corrected mitotic index (M/V index) was estimated in the same sections. Histologic grading was done in accordance with the WHO. The M/V index (p = 0.002), the nuclear area of the 10 largest nuclei (NA10) (p = 0.025), the histologic grade (p = 0.0956), the nuclear area (NA) (p = 0.038), the standard deviation of the nuclear perimeter (SDPE) (p = 0.033), and the standard deviation of the nuclear area (SDNA) (p = 0.0430) predicted survival in univariate analysis. The type of surgery performed was a significant prognosticator too (p = 0.0131). A multifactor regression analysis of survival including clinical and histologic factors identified the M/V index as the most important prognosticator (p = 0.009), followed by the type of surgery performed (p = 0.022). Other histologic factors had no independent prognostic value. Our results suggest the use of morphometric features instead of the conventional histologic grading in predicting survival of pancreatic ductal adenocarcinoma.
引用
收藏
页码:483 / 490
页数:8
相关论文
共 24 条
  • [1] INTRAOPERATIVE RADIOTHERAPY IN CARCINOMA OF THE STOMACH AND PANCREAS
    ABE, M
    SHIBAMOTO, Y
    TAKAHASHI, M
    MANABE, T
    TOBE, T
    INAMOTO, T
    [J]. WORLD JOURNAL OF SURGERY, 1987, 11 (04) : 459 - 464
  • [2] ALANEN K, 1990, SAMPLE PRESERVATIO D
  • [3] FACTORS INFLUENCING SURVIVAL AFTER TOTAL PANCREATECTOMY IN PATIENTS WITH PANCREATIC-CANCER
    ANDRENSANDBERG, A
    IHSE, I
    [J]. ANNALS OF SURGERY, 1983, 198 (05) : 605 - 610
  • [4] PANCREAS CANCER - DUCT CELL ADENOCARCINOMA - SURVIVAL IN RELATION TO SITE, SIZE, STAGE AND TYPE OF THERAPY
    CUBILLA, AL
    FITZGERALD, PJ
    FORTNER, JG
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1978, 10 (06) : 465 - 482
  • [5] Cubilla AL, 1984, TUMORS EXOCRINE PANC
  • [6] RELATIONSHIP BETWEEN DNA PLOIDY AND SURVIVAL IN PATIENTS WITH EXOCRINE PANCREATIC-CANCER
    ESKELINEN, M
    LIPPONEN, P
    COLLAN, Y
    MARIN, S
    ALHAVA, E
    NORDLING, S
    [J]. PANCREAS, 1991, 6 (01) : 90 - 95
  • [7] VOLUME CORRECTED MITOTIC INDEX (M/V-INDEX) - THE STANDARD OF MITOTIC-ACTIVITY IN NEOPLASMS
    HAAPASALO, H
    PESONEN, E
    COLLAN, Y
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1989, 185 (05) : 551 - 554
  • [8] HENSON DE, 1988, ARCH PATHOL LAB MED, V112, P1091
  • [9] HERMANNEK P, 1987, TNM CLASSIFICATION M
  • [10] KALSER MH, 1985, CANCER, V56, P397, DOI 10.1002/1097-0142(19850715)56:2<397::AID-CNCR2820560232>3.0.CO